SUMMARY. A pilot study was undertaken to find out whether faecal haemoglobin, albumin and ex-I-antitrypsin from patients with gastrointestinal disorders could distinguish active bleeders from non-active bleeders and healthy volunteers. Alpha-Iantitrypsin is not as readily degraded by endogenous and bacterial breakdown as haemoglobin and albumin and consequently could be a better marker for occult bleeding.
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Recently several workers have advocated the use of immunoassay for human haemoglobin (Hb) in faeces as an alternative to occult blood analysis based on peroxidase."? Measurement of intact human Hb is a more specific way to detect gastrointestinal (GI) bleeding as no dietary restrictions need to be observed by the patient. Although faecal Hb analysis can detect GI bleeding, the Hb molecule may become so degraded during its transport through the GI tract that its molecular structure may become unrecognisable to the antibody in the assay. It is possible to overcome this problem by employing an immunoassay for faecal ex-I-antitrypsin (ex-I-AT) which is not as susceptible to endogenous and bacterial enzymic degradation. Previously, ex-I-AT had been used to detect protein-losing enteropathies"? rather than whole blood loss. This paper provides preliminary evidence that ex-I-AT can be used as a sensitive marker ofGI disorders, picking up the majority of patients with GI bleeding, with the added bonus of detecting some patients with protein-losing enteropathies.
MATERIALS AND METHODS
The in vitro degradation of Hb, albumin and ex-I-AT in homogenates of faeces and distilled water at room temperature (17°-23°C) and at 37°C were determined in a preliminary study before the investigation of patients with gastrointestinal diseases. Table I lists these patients according to their disease category. All patients were classified after endoscopic and/or colonoscopic examination, that is, they were classified clinically and not on the basis of an occult blood test. It was not the purpose of this study to compare the usefulness of occult blood analysis with specific protein analysis.
Patients and controls

Reagents
The .following reagents were obtained from Sigma Chemical Company (Fancy Road, Poole, UK): human Hb, bovine, sheep and pig Hb, human ex-I-AT, antisera to human Hb (rabbit), antisera to human ex-I-AT (goat), calibrated human serum and brij 35 (30 % w/v). Other reagents used were human albumin (Behring, Salisbury Road, Hounslow TW4 6JH, UK), napthalene black TS (George T Gurr Ltd, London SW6, UK) and agarose (Miles Laboratories, Stoke Poges, UK).
Preparation of faecal homogenates for the degradation studies Fifteen faecal samples from nine patients were diluted with an equal volume of eithet 1·0giL of aqueous human haemoglobin or 1·0 giL aqueous albumin. Samples were rotary mixed for 15min and 0'5mL aliquots removed and placed immediately in a -20°C freezer. Other 2·0 mL aliquots were left stoppered at room temperature (17°-23 0c) or in a thermostatically controlled room at 37°C. Further 0'5mL aliquots from the room temperature and 37°e incubations were taken at 24, 48 and 72 h and frozen at -20 oe. All samples were stored at -20 "C until analysis, which was I week after the end of the incubations.
Another set of 17 faecal samples from 11 patients were treated and analysed in a similar manner. Here Hb, albumin and IX-I-AT were added to each sample by diluting each with an equal volume of an aqueous standard containing I'Og/L Hb, I·Og/L albumin and I'Og/L IX-I-AT. These samples were also incubated at room temperature and 37°e but for a longer time, 5·5 days.
A third set of seven faecal samples was incubated for 24 h at room temperature and 37°e, with haemolysed sera instead of aqueous Hb standard as the source of added Hb. These samples were analysed for Hb only.
Preparation of faecal extracts from controls and patients with GI disease
Stool samples were collected in universal containers and stored at -20 oe, within 4 h of collection. After thawing 3-10 g amounts of faecal samples were weighed accurately in sterile universal containers and 10-15 mL of 0·2 % brij 35 (30 % w/v) in distilled water was added to each container. The samples were vortex mixed for a few seconds and rotary mixed for 30 min. Afterwards, the samples were made up to 20 mL with further 0·2 % brij 35 (30 % w/v), returned to the rotary mixer for 15min and then centrifuged at 500 x g for 10min. Aliquots (5 mL) of each faecal extract were taken and stored at -20 0e until required for analysis.
Assays of faecal Hb, IX-I-AT and albumin
Faecal Hb and IX-I-AT were measured by radial immunodiffusion. A 1 % (wI v) solution of agarose in phosphate buffered saline (pH 7'2) containing 0·02 % (wI v) sodium azide was equilibrated to 56°e. An aliquot (4'6mL) of the agarose solution was gently mixed with 75J.lL of antisera to human haemoglobin for the faecal Hb assay or 50 J.lL of antisera to human IX-I-antitrypsin for the faecal IX-I-AT assay. The solutions were then poured onto 5 x 5 em glass plates and left to cool to room temperature. Twelve 2·5 mm diameter holes were punched into each gel. Haemoglobin standards were prepared by diluting whole blood of known Hb concentration with 0·2 % (wI v) brij 35 (30 % w/v) to give five standards in the range 0,1-1,5 gIL Hb while the IX-I-AT standards were prepared by diluting Sigma calibrated human sera in distilled water to give five solutions of IX-I-AT in the range 0,05-1·0gIL.
Aliquots of faecal extracts were thawed to room temperature and vortex mixed briefly. Five microlitres of an extract or standard was applied to each agarose gel well with a 10J.lL Hamilton syringe. The plates were left to incubate at room temperature for 24 h in a covered moist box and then washed in 0·9 % (wI v) saline solution for 24 h. Gels were pressed, air dried and stained Table 2 .
As expected, there was a significant correlation between faecal Hb and albumin for all the active bleeders r = 0,71, (P < 0,001). The best straight line gave: albumin = 0.117 Hb + 2·4.
The ratio 0·117 is close to that expected for Hb determined from the standard deviation of duplicates of 25 specimens in two independent batches.
Faecal albumin was determined by an 'in house' radioimmunoassay described previously."
RESULTS
Degradation of haemoglobin albumin and IX-I-antitrypsin by faecal homogenates The average rate of decay of Hb and albumin in all the faecal homogenates prepared for the in vitro studies was found to be IS % per 24 h at room temperature (17°-23 "C) and 60 % per 24 h at 37°C. No significant differences in the degradation rates were found between the three sets of faecal homogenates. Degradation rates in excess oDD % per 24 h were seen in homogenates incubated at room temperature for both Hb (IS % of homogenates) and albumin (28 % of homogenates). Haemoglobin and albumin degradation rates ranged from 0-33 % and 0-72 % decay per 24 h at room temperature, respectively.
In contrast, the average rates of degradation of IX-I-AT in the faecal homogenates was found to be less than 2 % per 24 h at room temperature and albumin in normal whole blood. The correlation between faecal Hb and (X-I-AT in the active bleeders was poor (r = 0·36, P = 0,1) and there was no significant correlation between albumin and (X-I-AT (r = 0'05, P > 0'5).
DISCUSSION
Traditional chemical methods to determine GI bleeding have been beset by problems of specificity due to dietary interfering factors. These widely used occult blood tests rely on the catalytic splitting of hydrogen peroxide by haemoglobin and its derivatives. The peroxidase-based tests are limited in specificity as the ingestion of red meat, iron supplements and peroxidase containing vegetables can contribute to the incidence of false positive results.!':" Furthermore, ingestion of Vitamin C can increase the number of false negative results." Specific immunoassays for human blood proteins in faecal specimens should theoretically overcome these specificity problems, and work with immunoassays , for human Hb has confirmed this idea.':"
There is, however, a theoretical problem about employing specific protein immunoassays in faecal samples; that of bacterial and endogenous protein degradation, both within the alimentary tract and during storage of specimens. The degradation can be such as to render the protein unrecognisable to the antisera, and therefore give a false negative result. This problem was highlighted in this study where the faecal Hb and albumin degradation rates in vitro were found to vary considerably, with extremes of nearly 100 % of these proteins remaining to nearly 0 % remaining after 24 h at 37 DC. The difference between the degradation rate of Hb and that of albumin in the same faecal homogenate was also found to vary considerably although the average rate of degradation of Hb was close to that for albumin. These differences are probably due to inter-individual variation in the bacterial composition of faeces. Clearly if degradation of albumin and Hb is to be kept to a minimum faecal samples should be cooled to 4 DC or frozen to -20 DC within several hours of passing the stool in order to minimise bacterial action. Barrows and Thomas added cocktails of antibiotics and antiproteases to patients' faecal samples in order to reduce the rate of Hb breakdown.!"
Our in vitro degradation studies support the finding of Florent and co-workers" that faecal (X-I-AT degrades at a much lower rate than other
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Presumably these degradation processes occuring in vitro could also be occuring during transit down the GI tract. Thus, albumin and Hb would be expected to be degraded more than (X-I-AT. This is reflected in the good correlation between faecal Hb and albumin values and the poor correlation seen between faecal Hb and (X-I-AT or faecal albumin and (X-I-AT values. The amount of degradation will vary between individuals, being dependent on bacterial growth, transit time, location and size of bleed, antibiotic therapy and exocrine pancreatic function. These degradative processes in the GI tract will reduce the predictive power of faecal Hb and albumin in diagnosing GI bleeding. A raised faecal Hb demonstrates active bleeding but a faecal Hb within the reference range does not demonstrate non-bleeding. This can be seen in the results shown in Figs I and 2 where there is some degree of overlap between the active bleeding group and the controls for both albumin and Hb. Although there are only a limited number of patients involved, the greatest overlap occured between the upper G I bleeding group and the controls, perhaps due to the greater degree of degradation that may be expected to occur in upper GI bleeders compared with lower GI bleeders. A very wide range of faecal albumin and Hb results were seen in the upper GI lesions, which could be due to a combination of this greater likelihood ofdegradation due to increased exposure to bacterial and endogenous proteases and to more massive bleeding sometimes associated with upper GI lesions.
One control faecal Hb value was much higher than all the other controls in this small study. Although, this patient was shown clinically not to have any GI disease, such a result may not be a true reflection of the reference range of values from controls. When we have conducted a fullscale prospective trial the 95 % confidence limits will probably be shown to be much lower than 2 mgjg weight for faecal Hb.
In vivo protein degradation did not appear to be a problem with (X-I-AT. Indeed the most striking feature of the scatter diagrams is the absence of overlap of faecal (X-I-AT values of controls and active bleeders (Fig. 3) . This preliminary study suggests that faecal ex-I-AT will provide a more sensitive test in the detection of GI bleeds than earlier faecal Hb or albumin measurements. In addition, like faecal Hb and albumin, ex-I-AT should not be prone to dietary interferences like the peroxidase based tests.
Measurement of a serum protein is not as specific in determining GI bleeding as a red blood cell protein like Hb. Inflammatory processes can give rise to protein-losing enteropathies and thus raised faecal ex-I-AT levels as seen in the small group of patients with active inflammatory disease (Fig. 3) . Faecal ex-I-AT has been used to detect Crohn's disease and other protein-losing enteropathies. Reported values in Crohn's patients have ranged from around 3·0 mg/g wet weight of faeces to well within the reference range of the control samples.'? Therefore, faecal ex-l-AT levels are raised in a proportion of proteinlosing enteropathy patients, and can be used to help to identify such patients. We believe this lack of specificity in the ex-I-AT measurement gives it a positive advantage as a first line screen for GI bleeding with the added bonus of detecting some protein-losing enteropathy patients. Both disorders need further investigation, so all positive results should be followed up. Faecal ex-I-AT measurements could be used as a sensitive and specific method for detecting GI diseases.
It is possible that a combination of the three protein measurements could yield extra diagnostic information. For instance, a positive faecal ex-I-AT and albumin in the presence of a negative faecal Hb could indicate a protein-losing enteropathy rather than a GI bleed. However, such combinations of tests are beset with problems like in vivo degradation and the fact that GI bleeding and protein-losing enteropathies can co-exist.
We are at present conducting a prospective trial investigating the possibility that faecal ex-l-AT measurements can be used as a sensitive and specific screening test to detect GI diseases, and can replace the present faecal occult blood tests and newer immunoassays for Hb.
